Stanford University, School of Medicine
Stanford, California, 95305, United States
NCT Number: NCT02365844
The purpose of this study is to characterize the blood supply at the base of the tongue and within the tonsil region. We hypothesize that high-resolution Narrow Band Imaging (NBI) will improve the diagnosis of oropharyngeal carcinoma (OPC). The goal is to provide the better assessment of tumor and thus providing better preoperative expectations to patients with OPC or tumor extent prior to radiation therapy.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Stanford, California, 95305, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 minutes
endoscopy of the oropharynx using white-light and narrow-Band imaging
Stanford University
Other
Multispectral Imaging to Characterize Patterns of Vascular Supply Within the Lymphoepithelial Mucosa of Patients With Known or Suspected Oropharyngeal Carcinoma (OPC)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06592716
Carcinoma, Carcinoma, Squamous Cell
Copenhagen, Denmark
View Trial DetailsNCT04788264
Head and Neck Carcinoma, Head and Neck Neoplasms
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT01440270
Head and Neck Neoplasms, Locally Advanced Malignant Neoplasm
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT01434394
Effects of Chemotherapy, Head and Neck Neoplasms
Shanghai, Shanghai Municipality, China
View Trial Details